4//SEC Filing
Parsons James T. 4
Accession 0001235802-22-000002
CIK 0001401040other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:21 PM ET
Size
5.4 KB
Accession
0001235802-22-000002
Insider Transaction Report
Form 4
Parsons James T.
Director
Transactions
- Award
Voting Common Shares, no par value per share
2022-01-03$3.58/sh+16,773$60,047→ 38,509 total
Footnotes (3)
- [F1]These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $60,000.
- [F2]Amount reflects the cancellation of 211 shares underlying deferred share units granted in lieu of Board committee retainers due to a change in Board committee memberships.
- [F3]Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 32,409 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001759855
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:21 PM ET
- Size
- 5.4 KB